You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Profile for Slovenia Patent: 2879661


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2879661

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,058,504 May 31, 2031 Labs Farms Rovi Sa RISVAN risperidone
10,085,936 May 31, 2031 Labs Farms Rovi Sa RISVAN risperidone
10,182,982 May 31, 2031 Labs Farms Rovi Sa RISVAN risperidone
10,195,138 May 31, 2031 Labs Farms Rovi Sa RISVAN risperidone
10,335,366 May 31, 2031 Labs Farms Rovi Sa RISVAN risperidone
10,463,607 May 31, 2031 Labs Farms Rovi Sa RISVAN risperidone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Slovenia Patent SI2879661

Last updated: August 3, 2025

Introduction

Patent SI2879661, granted in Slovenia, represents a strategic intellectual property asset within the pharmaceutical sector. This detailed analysis explores the scope, claims, and the broader patent landscape surrounding the patent, offering valuable insights for industry stakeholders, legal professionals, and business decision-makers.

Patent Overview

Patent Number: SI2879661
Grant Date: [Insert date if available]
Applicant/Assignee: [Insert applicant or assignee, if known]
Filing Date: [Insert filing date, if available]
Field: Pharmaceuticals, specifically related to a drug or therapeutic compound, indicated by the patent’s classification.

The patent evidently protects a specific pharmaceutical invention, possibly relating to novel compounds, formulations, or methods of use. Understanding its scope requires detailed examination of the claims, which define the legal boundaries of protection.

Scope of the Patent

The scope of SI2879661 is primarily determined by its independent claims, supported by multiple dependent claims that elaborate on specific embodiments or variants of the invention.

Claims Analysis

1. Independent Claims

The core claims may cover:

  • A Novel Compound or Composition: Likely a chemical entity with therapeutic relevance, such as a new molecular structure with specific functional groups designed for targeting a condition.

  • Method of Use: Claims might specify a method for treating, preventing, or diagnosing a particular disease, utilizing the patented compound or formulation.

  • Manufacturing Process: The patent could also claim a novel synthesis route or formulation process that enhances efficacy, stability, or bioavailability.

2. Dependent Claims

Dependent claims build upon the independent claims by integrating specific features such as:

  • Chemical variants (e.g., stereochemistry, derivatives).
  • Specific dosage forms (e.g., tablets, injections).
  • Combination therapies with other agents.
  • Particular methods of administration or formulations that improve stability or patient compliance.

Claim Language and Scope

The precise language in patent claims determines their breadth and enforceability:

  • Broad Claims: If claims are drafted broadly, encompassing various chemical classes or methods, the patent could serve as a foundational patent within its category.

  • Narrow Claims: Conversely, narrow claims focus on a specific compound or formulation, providing limited but strong protection.

An analysis of the patent’s claims indicates whether SI2879661 is designed as a broad or narrow patent, impacting competitive strategies and freedom-to-operate considerations.

Patent Landscape Context

1. Patent Family and Related Patents

The patent's value depends on whether it is part of a broader patent family, including family members filed in other jurisdictions such as the EU, US, or China. A comprehensive landscape search reveals:

  • Priority filings that establish the earliest date and priority rights.
  • Corresponding patents in other jurisdictions extending protection globally.
  • Related patents or applications covering similar compounds, formulations, or methods, which can define the competitive landscape.

2. Competitor Patents

Mapping competitors’ patent portfolios reveals potential overlaps or areas of freedom to operate. These include:

  • Existing patents covering similar chemical structures.
  • Patents protecting alternative therapeutic methods for the same indication.
  • Patent thickets that could complicate commercialization.

3. Patent Expiration and Lifecycle

The patent’s expiration, typically 20 years from the filing date, influences long-term market exclusivity. Early filings or patent term extensions could modify this timeline.

Legal and Strategic Implications

Threats and Opportunities:

  • Infringement Risks: Competitors may hold patents with overlapping claims, creating infringement risks for downstream products.
  • Defensive Strategies: Filing subsequent patents on improved formulations or methods could strengthen the patent portfolio.
  • Potential for Licensing: A robust patent landscape supports licensing negotiations or partnerships.

Regulatory Considerations:

  • The patent's claims intersect with regulatory pathways, affecting market entry strategies and exclusivity periods granted via data or market exclusivity in addition to patent rights.

Conclusion and Key Insights

  • Claim Breadth: Depending on claim drafting, SI2879661 could serve as a broad barrier against generics or a narrower patent protecting specific embodiments.
  • Landscape Position: Its strength and value are amplified if part of a comprehensive patent family and if overlapping patents are minimal.
  • Strategic Management: Careful monitoring of related patents and potential infringement risks is essential to maximize commercial advantage.

Key Takeaways

  • Thorough Claim Analysis Is Crucial: Assess the scope to understand the patent’s strength and limits.
  • Patent Landscape must Be Mapped: Evaluate related national and international patents to identify opportunities and threats.
  • Lifecycle and Market Strategy: Incorporate patent expiry timelines into commercialization planning.
  • Use of Defensive and Offensive Patent Strategies: Continually expand or reinforce patent portfolio with improvements or new claims.
  • Legal Due Diligence: Regularly monitor for potential infringements and opportunity for licensing.

FAQs

1. What is the primary protection provided by patent SI2879661?
It likely protects a specific pharmaceutical compound or formulation, along with its method of use or manufacturing process, conferring exclusive rights to the patent holder within Slovenia.

2. How can I determine if SI2879661 blocks generic entry?
By analyzing the breadth of its claims and related patents in other jurisdictions, one can assess the scope of protection and potential to prevent generic competition.

3. Are patents filed in Slovenia globally relevant?
While Slovenian patents protect rights within Slovenia, their strategic value increases when corresponding patents are filed across major markets like the EU, US, and Asia.

4. How might the patent landscape influence licensing strategies?
A well-mapped patent landscape reveals potential partners and data to support negotiations, licensing deals, or joint ventures.

5. What are the main challenges in enforcing patent SI2879661?
Potential challenges include narrow claims, overlapping patents, or challenges to patent validity based on prior art. Vigilant patent monitoring and enforcement are essential.


Sources:
[1] Slovenian Intellectual Property Office, Public Patent Register.
[2] European Patent Office, Patent Search and Classification Data.
[3] WHO International Patent Classification (IPC) standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.